Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - ACCOUNTS PAYABLE
Accounts Payable PRLD - Prelude Therapeutics Incorporated
4.58 M
LAST VALUE
-23.57%
2 YEAR CAGR
27.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR